{
    "2020-11-16": [
        [
            {
                "time": "",
                "original_text": "医药生物行业跨市场周报：估值切换政策密集 制造和消费属性企业价值有望凸显",
                "features": {
                    "keywords": [
                        "医药生物",
                        "估值切换",
                        "政策密集",
                        "制造和消费属性",
                        "企业价值"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "中国第五款新冠疫苗开启三期临床试验，由高福团队与智飞生物合研",
                "features": {
                    "keywords": [
                        "新冠疫苗",
                        "三期临床试验",
                        "高福团队",
                        "智飞生物"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "华兰生物分拆盛宴肥了谁？",
                "features": {
                    "keywords": [
                        "华兰生物",
                        "分拆",
                        "资本运作"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "A股异动丨智飞生物(300122.SZ)涨近4% 全资子公司的新冠疫苗进入三期临床试验",
                "features": {
                    "keywords": [
                        "A股异动",
                        "智飞生物",
                        "新冠疫苗",
                        "三期临床试验"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}